These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31262599)

  • 1. Phase II randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (IAP) during HIPEC (NCT02949791).
    Kusamura S; Azmi N; Fumagalli L; Baratti D; Guaglio M; Cavalleri A; Garrone G; Battaglia L; Barretta F; Deraco M
    Eur J Surg Oncol; 2021 Jan; 47(1):82-88. PubMed ID: 31262599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and respiratory implications of high intra-abdominal pressure during HIPEC.
    Reis ACV; Kusamura S; Azmi N; Fumagalli L; Piccioni F; Valenza F; Baratti D; Guaglio M; Cavalleri A; Garrone G; Barretta F; Deraco M
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1896-1901. PubMed ID: 32147425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High intra-abdominal pressure during hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) for peritoneal surface malignancies.
    Wong LCK; Wong JSM; Seo CJ; Soo KC; Ong CJ; Chia CS
    Int J Hyperthermia; 2022; 39(1):1195-1201. PubMed ID: 36096487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
    Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
    Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
    Somashekhar SP; Yethadka R; Kumar C R; Ashwin KR; Zaveri S; Rauthan A
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):577-581. PubMed ID: 31677939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
    Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
    In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center.
    Li XB; Ma R; Ji ZH; Lin YL; Zhang J; Yang ZR; Chen LF; Yan FC; Li Y
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):600-606. PubMed ID: 31973925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core Body Temperature but Not Intraabdominal Pressure Predicts Postoperative Complications Following Closed-System Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Administration.
    Goldenshluger M; Zippel D; Ben-Yaacov A; Dux J; Yalon T; Zendel A; Rayman S; Mor E; Berkenstadt H; Fogel-Grinvald H; Ventorrero M; Nissan A
    Ann Surg Oncol; 2018 Mar; 25(3):660-666. PubMed ID: 29285641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies.
    Kusamura S; Baratti D; Deraco M
    Ann Surg; 2012 Feb; 255(2):348-56. PubMed ID: 22202584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
    Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
    Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases.
    Narasimhan V; Das A; Warrier S; Lynch C; McCormick J; Tie J; Michael M; Ramsay R; Heriot A
    Langenbecks Arch Surg; 2019 Aug; 404(5):527-539. PubMed ID: 31377856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
    Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
    Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.
    Vaira M; Robella M; Mellano A; Sottile A; De Simone M
    Int J Hyperthermia; 2014 Dec; 30(8):565-9. PubMed ID: 25430988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pseudomyxoma peritonei with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a single center experience.
    Robella M; Vaira M; Marsanic P; Mellano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2013 Dec; 68(6):569-77. PubMed ID: 24193289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mentored experience of establishing a national peritoneal malignancy programme - Experience of first 50 operative cases.
    Chang KH; Kazanowski M; Staunton O; Cahill RA; Moran BJ; Shields C; Mulsow J
    Eur J Surg Oncol; 2017 Feb; 43(2):395-400. PubMed ID: 27955836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis.
    Cardi M; Sammartino P; Mingarelli V; Sibio S; Accarpio F; Biacchi D; Musio D; Sollazzo B; Di Giorgio A
    World J Surg Oncol; 2015 Oct; 13():305. PubMed ID: 26493405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience.
    Iversen LH; Rasmussen PC; Hagemann-Madsen R; Laurberg S
    Colorectal Dis; 2013 Jul; 15(7):e365-72. PubMed ID: 23458368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes
    Acs M; Halmy L; Isgandarova S; Blaj S; Gerken M; Hormann B; Piso P
    Anticancer Res; 2022 Feb; 42(2):1019-1029. PubMed ID: 35093903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.